EAHAD/LinkedIn
Sep 5, 2025, 14:12
EAHAD Podcast: Reducing Pain and Distress in Children Receiving Emicizumab
EAHAD (The European Association for Haemophilia and Allied Disorders) posted on LinkedIn:
”New Podcast Alert! Join us for the latest “Meet the Author Interview” with Maj Friberg Birkedal, Chair of the EAHAD Nurses Committee, discussing how the Neria Guard infusion set may help reduce pain and distress for children receiving emicizumab. Drawing on real-world experience, she highlights why even small innovations can make a big difference in paediatric care.
Tune in now.”
Stay updated with Hemostasis Today.
-
Mar 27, 2026, 18:13Ifeanyichukwu Ifechidere: ‘Almost Normal’ CBC Results Can Be the Most Dangerous
-
Mar 27, 2026, 18:09Supporting Research to Improve Outcomes in Bleeding Disorders – ASH
-
Mar 27, 2026, 18:06Haroun Gajraj: Effects of Combining Liquid Sclerotherapy with RF Thermocoagulation for Spider Veins
-
Mar 27, 2026, 18:02Maxime Dely: Apheresis and the Limits of Standardization in Healthcare Quality
-
Mar 27, 2026, 18:00Advancing Health Equity for Bleeding Disorders at the 79th World Health Assembly – WFH
-
Mar 27, 2026, 17:55Thomas Rocco Jr: How AI is Transforming the Management of High Blood Pressure and Cardiovascular Health
-
Mar 27, 2026, 17:52Nicolas Gendron: Challenges in Measuring NETs in Clinical Samples
-
Mar 27, 2026, 17:47Perla Bandini: Genetic and Functional Insights into Inherited Platelet Dysfunction
-
Mar 27, 2026, 17:43Heghine Khachatryan: Persistent Risks of Venous Thromboembolism in Pregnancy and Postpartum